Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Stomach

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Stomach in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duris, I; Kinova, S; Kovacova, E; Remkova, A1
Ishii, S; Izumi, T; Kato, S; Mutoh, H; Shimizu, T1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Stomach

ArticleYear
General changes in hemostasis in gastric cancer.
    Bratislavske lekarske listy, 2009, Volume: 110, Issue:4

    Topics: Adult; Aged; Blood Coagulation Factor Inhibitors; Female; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Stomach Neoplasms

2009
Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B.
    Biochemical and biophysical research communications, 1994, Dec-15, Volume: 205, Issue:2

    Topics: Base Sequence; Cell Line; Chloramphenicol O-Acetyltransferase; DNA Primers; Gene Expression Regulation, Neoplastic; Humans; Leukocytes; Molecular Sequence Data; NF-kappa B; Open Reading Frames; Platelet Activating Factor; Platelet Membrane Glycoproteins; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Up-Regulation

1994